SpyGlass Pharma Q4 EPS $(5.72) Down From $(4.58) YoY

SpyGlass Pharma (NASDAQ: SGP) reported a quarterly loss of $(5.72) per share for Q4, which represents a 24.89% increase in losses compared to $(4.58) per share in the same quarter last year.